article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. In fact, we got so many that we had to narrow them down to just the best and most interesting.

article thumbnail

Three Ways AI, If Trusted, Can Transform the Healthcare Landscape

Healthcare IT Today

From 3D-printed limbs to surgical robots , health providers have implemented AI to find creative treatment solutions for complex medical issues. We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.

BioTech 144
article thumbnail

Machine Learning in Pharma: Mindbreeze InSpire

Healthcare IT Today

The companies are evolving in many ways, including stepping outside drug development to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?

article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Email lloyd@nelsonadvisors.co.uk Subscribe Today! Buy, build or partner?

article thumbnail

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!

article thumbnail

Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures

Healthcare IT Today

“Flywheel’s products transform healthcare innovation by empowering organizations to efficiently and securely ingest, curate and share medical imaging data for accelerated research and AI development,” said Flywheel CEO, Jim Olson.